August 31, 2011 — Results of a recent randomized controlled study show the drug-eluting stent Xience V performs well in ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
August 31, 2011 — A recent study revealed more than 1,000 cardiac arrest deaths over 15 years are connected to the ...
August 30, 2011 – Primary percutaneous coronary intervention (PCI) is the best reperfusion therapy for patients ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
August 29, 2011 — The Guidelines on Peripheral Artery Disease (PAD) are the first document produced by the European ...
August 25, 2011 – Transcatheter structural heart occluder maker Occlutech said this week it closed a 15 million Euro ...
August 25, 2011 – The U.S. Food and Drug Administration (FDA) has released its list of pre-market approval (PMA) and 510 ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
August 23, 2011 — A new study shows heart attack patients are now being treated an average of 32 minutes faster than ...
August 23, 2011 — PLC Systems Inc. said the final results from the REMEDIAL II investigator-sponsored clinical trial ...
August 23, 2011 — Cardium Therapeutics received the final $1.1 million payment from Royal Philips Electronics in ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
August 19, 2011 - Neovasc Inc. accomplished $4.7 million in financing to complete the COSIRA clinical trial for the ...
August 18, 2011 — The antiplatelet agent prasugrel (trade name Effient), in combination with aspirin, was associated ...
August 17, 2011 — OrbusNeich announced its Genous stent showed no significant difference in target vessel failure (TVF) ...
During cardiology fellowship, my institution had a hand manifold system. I found it difficult to use at times, and it ...
August 17, 2011 — Our Lady of Lourdes Medical Center performed its first “hybrid” heart surgery and what is believed to ...
August 17, 2011 – Abbott announced today that the first patient in Japan has been treated with the Absorb bioresorbable ...
August 12, 2011— Simbionix USA Corp., a provider of medical simulation training and education products for medical ...